Publications by authors named "Jeremie Zerbit"

Claim this Profile
O
Outpatient Parenteral Antimicrobial Therapy in a Tertiary Hospital in France: A Description of Service Models and Costs.
Espérie Burnet, Alicia Le Bras, Guillaume Roucoux, Christian Dupont, Etienne Canouï, Jérémie Zerbit

Antibiotics (Basel)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure toxicity of venetoclax in acute myeloid leukemia patients in the real-life setting: impact of high exposure on delayed neutropenia.
Florent Puisset, Emmanuel Raffoux, Lionel Ades, Tony Huynh, Raphaël Itzykson, Jeremie Zerbit

Haematologica· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert Opinion on Managing Adverse Reactions Associated With Acalabrutinib Therapy: A Delphi Consensus From France.
Loïc Ysebaert, Stéphane Ederhy, Véronique Leblond, Stéphanie Malartre, Anaïs Portalier, Jérémie Zerbit

Clin Lymphoma Myeloma Leuk· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer care delivery during the Paris 2024 Olympic and Paralympic games: lessons from a crisis-driven Hospital at Home program.
Jeremie Zerbit, Cecile Chauvin, Arsene Zogo, David Avran, Frederique Moufle

Front Med (Lausanne)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maternal and obstetric outcomes in women with pregnancy-associated haematological malignancies: an observational nationwide cohort study.
Pierre Pinson, Ismael Boussaid, Justine Decroocq, Laurent Chouchana, Gary Birsen, Jeremie Zerbit

Lancet Haematol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Factors of Response to Immunotherapy in Lymphomas: A Multicentre Clinical Data Warehouse Study (PRONOSTIM).
Marion Detroit, Mathis Collier, Nathanaël Beeker, Lise Willems, Justine Decroocq, Jérémie Zerbit

Cancers (Basel)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmaceutical cancer care for haematology patients on oral anticancer drugs: Findings from an economic, clinical and organisational analysis.
Jeremie Zerbit, Marie Kroemer, Basile Fuchs, Marion Detroit, Justine Decroocq

Eur J Cancer Care (Engl)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remdesivir for Patients Hospitalized with COVID-19 Severe Pneumonia: A National Cohort Study (Remdeco-19).
Jeremie Zerbit, Marion Detroit, Sylvie Chevret, Frederic Pene, Charles-Edouard Luyt

J Clin Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with Hematological Malignancies Treated with T-Cell or B-Cell Immunotherapy Remain at High Risk of Severe Forms of COVID-19 in the Omicron Era.
Jeremie Zerbit, Marion Detroit, Antoine Meyer, Justine Decroocq, Benedicte Deau-Fischer

Viruses· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Redifferentiating Effect of Larotrectinib in -Rearranged Advanced Radioactive-Iodine Refractory Thyroid Cancer.
Lionel Groussin, Hélène Theodon, Laura Bessiene, Leopoldine Bricaire, Fidéline Bonnet-Serrano, Jérémie Zerbit

Thyroid· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma.
Soledad Henriquez, Jérémie Zerbit, Timothée Bruel, Amani Ouedrani, Delphine Planas

Blood· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asciminib and ponatinib combination in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Jérémie Zerbit, Jerome Tamburini, Lauriane Goldwirt, Justine Decroocq, Jean Michel Cayuela

Leuk Lymphoma· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Access and use of quinacrine (mepacrine) in the treatment of resistant giardiasis.
Clemence Delaye, Felipe Suarez, Claire Aguilar, Corinne Guerin, Rui Batista, Jeremie Zerbit

Infect Dis Now· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Selpercatinib-Enhanced Radioiodine Uptake in RET-Rearranged Thyroid Cancer.
Lionel Groussin, Laura Bessiene, Jennifer Arrondeau, Simon Garinet, Béatrix Cochand-Priollet, Jérémie Zerbit

Thyroid· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma Concentrations and Safety of Lopinavir/Ritonavir in COVID-19 Patients.
Laurent Chouchana, Sana Boujaafar, Ines Gana, Laure-Hélène Preta, Lucile Regard, Jeremie Zerbit

Ther Drug Monit· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines).
Florian Slimano, Amandine Baudouin, Jérémie Zerbit, Anne Toulemonde-Deldicque, Audrey Thomas-Schoemann

Cancer Treat Rev· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved time to treatment failure and survival in ibrutinib-treated malignancies with a pharmaceutical care program: an observational cohort study.
Jeremie Zerbit, Sylvie Chevret, Sophie Bernard, Marie Kroemer, Charlotte Ablard

Ann Hematol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis